小麦叶绿体中细胞分裂素结合蛋白的功能

采用ＢＡ－Ｓｅｐｈａｒｏｓｅ６Ｂ亲和层析法从小麦叶绿体中纯化了ＣＴＫ结合蛋白并制备了抗体。小麦叶绿体经ＣＴＫ结合蛋白的抗体处理后,表现出：希尔反应活力降低;ＭＶ（包括光系统Ｉ和Ⅱ）和ＰＭＳ（包括光系统Ｉ）系统的毫秒延迟发光的慢相强度下降;光合磷酸化活力受到抑制。说明小麦叶绿体中的ＣＴＫ结合蛋白存在状态的改变会影响叶绿体的能量转换过程。     

小麦叶绿体中细胞分裂素结合蛋白的功能

采用ＢＡ－Ｓｅｐｈａｒｏｓｅ ６Ｂ亲和层析法从小麦叶绿体中纯化了ＣＴＫ结合蛋白并制备了抗体。小麦叶绿体经ＣＴＫ结合蛋白的抗体处理后,表现出：希尔反应活力降低;ＭＶ（包括光系统Ⅰ和Ⅱ）和ＰＭＳ（包括光系统Ⅰ）系统的毫秒延迟发光的慢相强度下降,光合磷酸化活力受到抑制,说明小麦叶绿体中的ＣＴＫ结合蛋白存在状态的状态的改变会影响叶绿体的能量转换过程。     

亲和素结合蛋白性质的研究

前曾发现在日本血吸虫虫卵中,存在一种新的能与亲和素专一性结合的蛋白质,称为亲和素结合蛋白（ＡＢＰ）。在分离纯化ＡＢＰ的基础上,用ＳＤＳ－ＰＡＧＥ及ＳｅｐｈａｄｅｘＧ－１５０分别测定了ＡＢＰ的分子量,并做了糖蛋白染色及等电,大测定。实验结果表明ＡＢＰ是一个分子量为６５ｋＤ的碱性糖蛋白,由数个相同的分子量为１２．７ｋＤ的亚单位组成。ＳＤＳ、β－巯基乙醇处理的ＡＢＰ仍能与亲和素结合,提示ＡＢＰ的亚单位能与亲和素结合。氨基酸修饰剂ＮＡＩ、ＤＴＮＢ、ＮＥＭ及ＮＢＳ对ＡＢＰ与亲和素的结合有不同程度的影响,而ＨＮＢＢ、ＴＮＢＳ及ＩＡＡ对ＡＢＰ与亲和素的结合无影响,提示ＡＢＰ分子中氨基酸残基Ｔｙｒ、Ｃｙｒ是ＡＢＰ与亲和素结合所必需的,可能参与结合位点的形成。另外,测得ＡＢＰ与亲和素结合的结合常数为１．４×１０~（－７）ｍｏｌ／Ｌ。     

蚕豆叶片下表皮ABA结合蛋白的分离纯化

将ＡＢＡ通过一个１０ 碳原子的臂高效率地（６～８ ｍｍｏｌ／Ｌ凝胶）偶联到琼脂糖凝胶４Ｂ上,制成亲和层析柱,用以纯化蚕豆（Ｖｉｃｉａｆａｂａ Ｌ．） 叶片下表皮ＡＢＡ 结合蛋白（ＡＢＡ＿ＢＰ）。样品上柱后,通过ＮａＣｌ 盐梯度洗脱去掉大部分非特异结合的杂蛋白后,用１ ｍｍｏｌ／ＬＡＢＡ亲和洗脱竞争亲和柱中的ＡＢＡ＿ＢＰ,纯化到一种ＡＢＡ特异结合蛋白,纯化了１１２ 倍。纯化蛋白与ＡＢＡ 最大结合为５８．３３ ｎｍｏｌ／ｇ ｐｒｏｔｅｉｎ,Ｋｄ 值为２１ ｎｍｏｌ／Ｌ,亚基分子量为４４ ．２ ｋＤ,纯度约为９０ ％ 。纯化的ＡＢＡ结合蛋白具有典型的蛋白质紫外吸收光谱,在２８０ ｎｍ 处有明显吸收峰     

脱落酸(ABA)受体的研究进展

植物激素脱落酸（ＡＢＡ）在植物对逆境适应及种子发育过程中具有重要的生理功能。尽管ＡＢＡ作用的分子机制还不清楚,ＡＢＡ受体还未得到鉴定,但近年来对ＡＢＡ结合蛋白的研究取得了可喜的进展,已在多种植物中证明存在与ＡＢＡ有高亲和力的结合蛋白。ＡＢＡ的识别到底发生在胞外还是胞内,近几年随着微注射技术的应用,也得到不少实验证据。ＡＢＡ信号的转导途径,特别是位于下游区域参与信号传递的物质的研究取得重大进展,其中以ＡＢＡ调节气孔保卫细胞开关的信号传递成为研究这一领域的模式体系。     

葡萄果实中脱落酸结合蛋白的存在及其性质

葡萄果实微粒体上存在高亲和力的脱落酸（ＡＢＡ）结合位点,这些位点与ＡＢＡ的结合具有饱和性,高亲和力及低容量,胰蛋白酶或ＤＴＴ处理可以使该位点的特异结合活性下降约９０％,表明此结合位点是一种蛋白质,故称为ＡＢＡ结合蛋白,它含有维系蛋白质特定构象的二硫键,该蛋白与ＡＢＡ反应的最适ｐＨ为６．０,说明与配基结合部位可能存在带有正电荷的氨基酸残基,结合活性在２５℃高于０℃,结合反应达到动态平衡需要３０ｍｉｎ,３０ｍｉｎ以后结合活性随时间延长而下降。该蛋白与ＡＢＡ结合反应的平衡解离常数为１７．５ｎｍｏｌ／Ｌ,最大结合容量（Ｂｍａｘ）为９８．４ｆｍｏｌ／ｍｇｐｒｏｔｅｉｎ。     

抗生物素蛋白结合蛋白的发现及分离纯化

本文报道了在日本血吸虫感染的兔血清及日本血吸虫卵中,存在一种能与抗生物素蛋白（又称亲和素）专一性结合的蛋白质,称为抗生物素蛋白结合蛋白。该蛋白质与亲和素的结合与生物素及亲和素的糖链部分无关,并能在高ＰＨ、高浓度盐及去污剂等条件下与亲和素结合。利用ＤＥＡ－５２离子交换柱及偶联有亲和素的Ｓｅｐｈａｒｏｓｅ４Ｂ亲和层析柱,从日本血吸虫感染的兔血清中,分离纯化了该蛋白质。提纯的亲和素结合蛋白在ＳＤＳ－ＰＡ     

葡萄果实中脱落酸结合蛋白的存在及其性质

葡萄果实微粒体上存在高亲和力的脱落酸（ＡＢＡ）结合位点,这些位点与ＡＢＡ的结合具有饱和性,高亲和力及低容量。胰蛋白酶或ＤＴＴ处理可以使该位点的特异结合活性下降约９０％,表明此结合位点是一种蛋白质,故称为ＡＢＡ结合蛋白,它含有维系蛋白质特定构象的二硫键。该蛋白与ＡＢＡ反应的最适ｐＨ为６．０,说明与配基结合部位可能存在带有正电荷的氨基酸残基,结合活性在２５℃高于０℃,结合反应达到动态平衡需要３０ｍｉｎ     

用ANS研究脱落酸提高植物线粒体膜的流动性

用荧光标记法,以ＡＮＳ作荧光探剂研究了脱落酸（ＡＢＡ）对植被线粒体脱流动性的影响。（＋）ＡＢＡ浓度效应实验结果和不同ＰＨ及不同温度条件下的实验结果均表明（＋）ＡＢＡ能降低植物线粒体膜的荧光强度,即（＋）ＡＢＡ能提高线粒体原流动性,且此种效应具有浓度饱和性,并导致线粒体异柠檬酸脱氢酶（ＩＣＨ）活性升高。ＡＢＡ的类似物,ＲＣＡ．７Ａ和ＲＣＡ．７ｂ,也具有提高ＩＣＤＨ活性的效应,抗ＡＢＡ结合蛋白的抗体（     

甲醇对蚕豆气孔开启的影响

在一定的深度范围内,甲醇能促进蚕豆气孔的开启,最适浓度为１．５％,与６－苄基腺嘌呤（６－ＢＡ）有协同增效作用,对脱落酸（ＡＢＡ）有拮抗作用。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).